Extramammary Paget's disease in males: survival outcomes in 495 patients

Lindsey A Herrel1, Aaron D Weiss, Michael Goodman

  • 1Department of Urology, Emory University, Atlanta, GA, USA.

Annals of Surgical Oncology
|November 12, 2014
PubMed
Abstract

Insights

Extramammary Paget's disease (EMPD) survival in men is lower for perianal tumors and older age. Incidence of this rare cancer is increasing, with racial disparities observed.

Area of Science:

  • Oncology
  • Epidemiology
  • Dermatology

Background:

  • Extramammary Paget's disease (EMPD) is a rare intraepithelial malignancy with limited outcome data.
  • In men, EMPD predominantly affects the perianal and penoscrotal regions.
  • Understanding incidence, trends, and survival predictors is crucial for this patient population.

Purpose of the Study:

  • To assess the incidence and time trends of EMPD in men.
  • To determine the extent and predictors of survival for male EMPD patients.
  • To analyze demographic and clinical factors influencing EMPD outcomes.

Main Methods:

  • Utilized data from 18 Surveillance, Epidemiology, and End Results (SEER) registries (1973-2009).
  • Categorized cases by primary skin location (perianal, penoscrotal, other truncal).
  • Employed Kaplan-Meier, univariate, and multivariate Cox regression analyses.

Main Results:

  • EMPD incidence in men shows a significant annual increase of +3.2% since 1978.
  • Incidence was lower in Black men and higher in Asian/Pacific Islander men compared to White men.
  • Negative survival predictors included perianal primary site, age >75 years, and distant disease stage.

Conclusions:

  • Survival outcomes for men with EMPD are poorer with distant disease and perianal primary tumors.
  • The rising incidence and observed racial disparities in EMPD require further investigation.
  • Identifying specific reasons for these trends and disparities is essential for future research and clinical management.